Prevention of delayed neuronal cell death by PACAP and its molecular mechanism
Prevention of delayed neuronal cell death by PACAP and its molecular mechanism
批准号:
14380354
负责人:
SHIODA Seiji
金额:
$9.47万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2004
中文摘要
PACAP可预防海马区缺血性迟发性神经细胞死亡(凋亡性炎症)。PACAP抑制MAP激酶家族的活性,特别是JNK/SAPK和p38的活性,从而保护细胞的死亡。脑缺血再灌注后,锥体细胞和星形胶质细胞的PACAP受体(PAC1-Rs)表达均增加。锥体细胞变性,反应性星形胶质细胞增加其PAC1-R的表达。PACAP不仅直接抑制细胞凋亡,而且通过PAC1-Rs作用于星形胶质细胞。白介素6(IL-6)是由星形胶质细胞产生的,在预防脑缺血和创伤、刺激神经元生长方面具有多种作用。PACAP对脑脊液中IL-6的分泌有极强的刺激作用,提示PACAP可刺激星形胶质细胞分泌IL-6。我们研究了PACAP对脑缺血后野生型和IL-6KO小鼠的影响。在野生型动物中,PACAP显著抑制细胞死亡,而在IL-6 KO动物中,PACAP没有明显的细胞保护作用。这些结果表明,PACAP部分通过IL-6抑制细胞凋亡。据认为,PACAP本身和IL-6在PACAP刺激分泌的同时,都协同抑制JNK/SAPK和p38信号通路,从而保护神经细胞死亡。(1677字)
英文摘要
Ischemic delayed neuronal cell death (apoptotis) in the hippocampus is prevented by PACAP. PACAP inhibits the increasing activity of the MAP kinase family, especially on JNK/SAPK and p38, thereby protecting apoptotic cell death. After the ischemia-reperfusion, both pyramidal cells and astrocytes increased their expression of PACAP receptors (PAC1-Rs). The pyramidal cells degenerated but reactive astrocytes increased their expression of PAC 1-R. PACAP does not only inhibit apoptotic cell death directly, but also affects on astrocytes through PAC1-Rs. Interleukin-6 (IL-6), produced in astrocytes, has several effects on prevention of brain ischemia and trauma and stimulating neuronal growth. IL-6 secretion into the CSF was stimulated extremely after PACAP infusion, suggesting that PACAP stimulates IL-6 secretion from astrocytes. We studied the effects of PACAP on the wild type and IL-6 KO mice after brain ischemia. In wild-type animals, PACAP significantly inhibited cell death but in IL-6 KO animals no cytoprotective effect of PACAP was seen. These results suggest that PACAP inhibits apoptotic cell death partly through IL-6. It is considered that PACAP itself and IL-6, stimulated secretion by PACAP, both synergistically inhibit the JNK/SAPK and p38 signaling pathway, thereby protecting neuronal cell death. (1677 Words)
期刊论文(202)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
--
发表时间:
2004
期刊:
Brain Res. 1016
影响因子:
--
作者:
[Chiyonobu T, Sasaki J, Nagai Y, Takeda S, Funakoshi H, Nakamura T, Sugimoto T, Toda T, Nonaka N.]
通讯作者:
Nonaka N.
Morphological analysis of ghrelin and its receptor in the rat pancreas
大鼠胰腺ghrelin及其受体的形态学分析
DOI:
--
发表时间:
2005
期刊:
Regul Pept 126
影响因子:
--
作者:
[Kageyama H]
通讯作者:
Kageyama H
Ohtaki, H.: "Evaluation of neuronal cell death after a new global ischemia model in infant mice."Acta Neurochir. 86(Suppl). 97-100 (2003)
Ohtaki, H.:“对婴儿小鼠新的全局缺血模型后神经元细胞死亡的评估。”Acta Neurochir。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ohtaki, H.: "Suppression of oxidative stress after transient focal ischemia in interleukin-1 knock out mice."Acta Neurochir. 86(Suppl). 191-194 (2003)
Ohtaki, H.:“白介素 1 敲除小鼠短暂局灶性缺血后氧化应激的抑制。”Acta Neurochir。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Zhou, CJ.: "Pleiotropic effects of PACAP and multiple signaling pathways under its receptors in nervous system"Curr Protein & Peptide Sci. 3. 423-439 (2002)
Zhou, CJ.:“PACAP 的多效性及其受体在神经系统中的多种信号通路”Curr 蛋白
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 76 条
A new strategy to conquer obesity by use of a newly discovered neuropeptide GALP
-
批准号:21659059
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$1.96万
-
财政年份:2009
-
负责人:SHIODA Seiji
-
依托单位:
Demonstration of PACAP on protection of delayed neuronal cell death and its molecular mechanism of neuroregeneration.
-
批准号:20390461
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.4万
-
财政年份:2008
-
负责人:SHIODA Seiji
-
依托单位:
Functional significance of tumor necrosis factor alpha in inducing retinal ganglion cell death by using gene targeting method
-
批准号:11671758
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.5万
-
财政年份:1999
-
负责人:SHIODA Seiji
-
依托单位:
Functional significance of PACAP receptors in regulating secretion and synthesis of vasopressi
-
批准号:10680708
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:1998
-
负责人:SHIODA Seiji
-
依托单位:
Functional significance of PACAP in inhibiting neuronal cell death by using gene targeting method
-
批准号:09558098
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$5.76万
-
财政年份:1997
-
负责人:SHIODA Seiji
-
依托单位:
PACAP as a neuronal cell death in hibiting function
-
批准号:08458249
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.29万
-
财政年份:1996
-
负责人:SHIODA Seiji
-
依托单位:
国内基金
海外基金
登录
查看更多内容
早期滋养型肠内营养联合益生菌对重症卒中患者喂养耐受性及TNF-α/IL-6水平的影响研究
-
批准号:2026JJ81631
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:廖思思
-
依托单位:
七氟烷通过调控IL-6/FSP1轴抑制心肌铁死亡减轻心肌缺血再灌注损伤的机制研究
-
批准号:JCZRLH202601296
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
盐酸小檗碱抑制NF-κB/IL-6/STAT3信号通路重塑免疫微环境并增敏肺癌免疫治疗的研究
-
批准号:JCZRLH202600985
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
双歧杆菌与消退素RvD1协同调控IL-6/STAT3/Notch信号轴介导结肠癌EMT及免疫调节的机制研究
-
批准号:JCZRLH202601410
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于"热证可灸"理论的中药联合铺棉灸治疗带状疱疹急性期的临床疗效及对血清SP、β-EP、IL-6、IL-10、NSE水平的影响
-
批准号:2026JJ81075
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:黄迎春
-
依托单位:
基于“截断扭转”学说探讨凉膈散通过IL-6/STAT3/RORγt轴调控脓毒症Th17/Treg稳态的机制及临床研究
-
批准号:2026JJ82600
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:黄磊
-
依托单位:
基于IL-6/STAT3通路巨噬细胞极化调控免疫反应在胸膜结核瘤形成中的机制
-
批准号:2026JJ82516
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张锋
-
依托单位:
早产儿脑白质损伤的 MRI 影像学特征联合炎症因子组合(IL-6、TNF-α、IL-1β)与神经系统损害关联研究
-
批准号:JCZRLH202601761
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
肺上皮细胞SHIP1通过IL-6/GLS1轴调控成纤维细胞脯氨酸代谢重编程在肺纤维化中的机制研究
-
批准号:JCZRQNB202600510
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
炎症因子组合(IL-6、TNF-α、IL-1β)动态监测在极低出生体重儿坏死性小肠结肠炎早期预测中的价值研究
-
批准号:JCZRLH202601488
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位: